Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

Studies at IAS 2013 Look at ART Side Effects

Studies at IAS 2013 Look at ART Side Effects

, by Liz Highleyman

Modern HIV meds are more tolerable than older drugs, but even the most widely used can lead to problems for some individuals. Read More

Antiretroviral Therapy News from IAS 2013

Antiretroviral Therapy News from IAS 2013

, by Liz Highleyman

Learn about the HIV treatment refinements—including lower drug doses and monthly injections vs. daily pills—described at last week’s conference in Kuala Lumpur. Read More

Experts Discuss Drug Policy at IAS 2013

Experts Discuss Drug Policy at IAS 2013

, by Liz Highleyman

"It is time for drugs to be seen as health problem and not a criminal problem," says Michel Kazatchkine, UN Special Envoy on HIV/AIDS in Eastern Europe and Central Asia. Read More

IAS 2013 Keynote Looks at Aging with HIV

IAS 2013 Keynote Looks at Aging with HIV

, by Liz Highleyman

HIV and aging, new antiretroviral treatment guidelines, and the impacts of drug policy on HIV and hep C epidemics were the focus of day one at the International AIDS Society Conference. Read More

EASL 2013: New Wave of Hepatitis C Treatments On the Way

EASL 2013: New Wave of Hepatitis C Treatments On the Way

, by Liz Highleyman

A new generation of safer and better hep C therapies is coming, according to research presented at the EASL International Liver Congress. Find out what's in the pipeline. Read More